Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB)
about
Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivoInducing chemotactic and haptotactic cues in microfluidic devices for three-dimensional in vitro assays.The elongated first fibronectin type III domain of collagen XIV is an inducer of quiescence and differentiation in fibroblasts and preadipocytesCharacterization and expression analysis of SOLD1, a novel member of the retrotransposon-derived Ly-6 superfamily, in bovine placental villi.Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis.Role of growth factors and their receptors in gastric ulcer healing.How does the pathophysiological context influence delivery of bone growth factors?Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Fibroblast Migration in 3D is Controlled by Haptotaxis in a Non-muscle Myosin II-Dependent Manner.Formulated collagen gel accelerates healing rate immediately after application in patients with diabetic neuropathic foot ulcersMapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors.Transduction of extracellular cues into cell polarity: the role of the transmembrane proteoglycan NG2.Stress-induced ECM alteration modulates cellular microRNAs that feedback to readjust the extracellular environment and cell behavior.Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI).Osteocalcin/fibronectin-functionalized collagen matrices for bone tissue engineering.SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis.Engineering and application of collagen-binding fibroblast growth factor 2 for sustained release.Fibroblast growth factor 2-functionalized collagen matrices for skeletal muscle tissue engineering.Estradiol inhibits hyaluronic acid synthase 1 expression in human vascular smooth muscle cells.Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.Therapeutic potential of novel modulators of neovascularization.The collαgen III fibril has a "flexi-rod" structure of flexible sequences interspersed with rigid bioactive domains including two with hemostatic roles.The biochemistry of cancer dissemination.Conversion from cyclosporin A to sirolimus retards the progression of chronic allograft nephropathy in the long term in a rat kidney transplantation model.The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline.Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.PDGF binds to extracellular matrix proteinsInterstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M.
P2860
2cf306ff6e1d644fe80b1121834c7f2a8886452a4f7c19d3acddc31160baa8bd6b90caea3597ac9d66f21fd53bfd008eb74427404f31335801ecb1bf6ec2591674080877e9f1638ca426faff422a814a890d7c5b17234dd01e27d7e519c87522026110b28ed27288ce35a81021305e71f52feed88742bee7b16872f9a4384b88c68041c76c38dcf2434d80bbcadf099c8db4389148a7c7865da59685da93514ef24f54c3a79d813f8745aed65e743d49ec100b3e
P248
Q22001540-21CF1BD6-D20F-43BD-ABC1-F1048C21E8A4Q27332366-C9DB5463-E14E-4F87-AEB3-83C7A29C782CQ28269609-8F5DB19C-578D-4AC4-B2B0-827ECFEE49BCQ33463427-D98EBA25-446D-45DF-8BA0-E71C985095A7Q34005608-3ACE36AA-EE97-406E-B7F9-A4783AD5EA29Q34263687-6FE12777-2231-4DAE-BB4E-1E7DAA262FD2Q35463054-93FB4C5E-F089-42D5-A935-BC637BD30FF5Q35622533-26A859E9-F92D-4177-AE14-AF9358D9156DQ36214808-F29B82D7-6231-424B-80B4-8C6C9A7BF329Q36236927-69ACD65D-AB67-4E4C-A654-5DBF9FCCFF6DQ36709721-3F30298E-AAED-4CAF-BC8A-00144494324FQ36990691-EE9DF16F-D8AF-44B3-B8FF-28DF1408B1DCQ38175867-9FC48A81-3BE0-4E46-83AD-CC520341F477Q38178664-360CA83C-13E5-4100-B668-AF05379C1B4EQ38786643-AB1F4352-668C-4B9C-B6D6-823111AB0B03Q38944994-C7C38B75-F8C0-48D2-981C-B9CEEC9BF3D5Q39178715-456E1478-27C9-4E83-90D7-F31F691D3288Q39184080-CAA9272C-8681-43A3-9778-62C4DD071DF7Q39429743-D251959F-F17F-4608-A27D-96E16E7B9A2EQ39477502-8E59888F-AD31-4A44-BE13-D0D0A83DC31FQ39830487-4AB9DAE5-9528-49FE-9367-EFE09D5C83B1Q40076736-052B2C7C-4DBB-4465-B783-8532ED2EE2BAQ41006430-3E5EFE60-4013-4D8D-AD28-4C244FB863DAQ41547351-E0DA8494-3CC0-44E7-9864-8FD81590C65CQ43237438-40E050D1-75B8-4357-824A-2F8794DCF01BQ43969948-E2F079EC-3541-4C5C-BE55-86FB3C433138Q46748582-C5B6E0C1-1CD7-45BC-8EED-7E7442568A57Q50297833-83CDDE25-80A0-4C23-A801-27CB22C4AA41Q52960794-8425BBFB-A6FB-48D0-A761-107C07462CA5
P2860
Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB)
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@ast
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@en
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@en-gb
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@nl
type
label
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@ast
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@en
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@en-gb
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@nl
prefLabel
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@ast
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@en
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@en-gb
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@nl
P921
P356
P1476
Type I, II, III, IV, V, and VI ...... growth factor (AA, BB, and AB)
@en
P2093
D Schuppan
R Somasundaram
P304
P356
10.1074/JBC.271.43.26884
P407
P577
1996-10-25T00:00:00Z